These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29955479)

  • 1. Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder.
    Chou F; Reome E; Davis P
    Ment Health Clin; 2016 Sep; 6(5):254-259. PubMed ID: 29955479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients.
    Chowdhury D; Greer D; Liu MT; McCarthy C; Maroney M
    Ment Health Clin; 2024 Apr; 14(2):92-96. PubMed ID: 38694886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia.
    Wei Y; Yan VKC; Kang W; Wong ICK; Castle DJ; Gao L; Chui CSL; Man KKC; Hayes JF; Chang WC; Chan EW
    JAMA Netw Open; 2022 Jul; 5(7):e2224163. PubMed ID: 35900760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder.
    Devrımcı Özgüven H; Kir Y
    Noro Psikiyatr Ars; 2021; 58(Suppl 1):S47-S52. PubMed ID: 34658635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of long-acting injectable antipsychotics versus oral antipsychotics in the maintenance treatment of outpatients with chronic schizophrenia.
    Fang SC; Liao DL; Huang CY; Hsu CC; Cheng SL; Shao YJ
    Hum Psychopharmacol; 2020 May; 35(3):e2729. PubMed ID: 32182388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations.
    Thaman P; Kulig CE; Greer D
    J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):96-99. PubMed ID: 38227617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of readmission data between different categories of antipsychotic drugs at a state psychiatric hospital in Oregon.
    Baker J; Aebi C
    Ment Health Clin; 2017 May; 7(3):124-130. PubMed ID: 29955510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
    Maestri TJ; Mican LM; Rozea H; Barner JC
    Psychopharmacol Bull; 2018 Mar; 48(3):8-15. PubMed ID: 29713100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia--A 3-year follow-up.
    Liu CC; Shan JC; Chiang CL; Hsieh MH; Liu CM; Chien YL; Chen SC; Hwang TJ
    J Formos Med Assoc; 2015 Jun; 114(6):539-45. PubMed ID: 26062967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.
    Morris MT; Tarpada SP
    Psychopharmacol Bull; 2017 May; 47(2):42-52. PubMed ID: 28626271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of adherence in patients prescribed long-acting injectable antipsychotics: A comparison of biweekly versus monthly administered neuroleptics.
    Carr CN; Hall CP; Roche-Desilets JE; Burant CJ; Fuller MA
    Ment Health Clin; 2016 Sep; 6(5):248-253. PubMed ID: 29955478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Outcomes Between Risperidone Microspheres and Paliperidone Palmitate Long-Acting Injectable Antipsychotics Among Veterans.
    Ibrahim HG; Malcolm BJ; Gogineni HP
    Fed Pract; 2021 Dec; 38(12):586-591. PubMed ID: 35177888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.
    Parellada E; Bioque M
    CNS Drugs; 2016 Aug; 30(8):689-701. PubMed ID: 27255405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.
    Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E
    Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment adherence with early prescription of long-acting injectable antipsychotics in recent-onset schizophrenia.
    Viala A; Cornic F; Vacheron MN
    Schizophr Res Treatment; 2012; 2012():368687. PubMed ID: 22966435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics.
    MacEwan JP; Kamat SA; Duffy RA; Seabury S; Chou JW; Legacy SN; Hartry A; Eramo A; Karson C
    Psychiatr Serv; 2016 Nov; 67(11):1183-1188. PubMed ID: 27417897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study.
    Buckley PF; Schooler NR; Goff DC; Kopelowicz A; Lauriello J; Manschreck TC; Mendelowitz A; Miller DD; Wilson DR; Ames D; Bustillo JR; Kane JM; Looney SW
    Psychiatr Serv; 2016 Dec; 67(12):1370-1372. PubMed ID: 27476806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
    McEvoy JP; Byerly M; Hamer RM; Dominik R; Swartz MS; Rosenheck RA; Ray N; Lamberti JS; Buckley PF; Wilkins TM; Stroup TS
    JAMA; 2014 May; 311(19):1978-87. PubMed ID: 24846035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia.
    Kaplan G; Casoy J; Zummo J
    Patient Prefer Adherence; 2013; 7():1171-80. PubMed ID: 24265549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.